Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Inflammatory Bowel Diseases × Adalimumab × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 9 Spondylitis, Ankylosing 2 Spondylarthritis 1 Psoriasis 1 Joint Diseases 1 Inflammatory Bowel Diseases 1 Crohn Disease 1 Colitis, Ulcerative 1 Autoimmune Diseases 1 Arthritis 1

Interventions

Infliximab 2 golimumab 1 Papillomavirus Vaccines 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Calcium Dobesilate 1 CT-P13 1 Bupivacaine 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04646187 2025-01-06

FREE

University Medical Center Groningen

Phase 4 Enrolling by invitation

Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡